G1 Therapeutics Inc (GTHX)-製薬・医療分野:企業M&A・提携分析

【英語タイトル】G1 Therapeutics Inc (GTHX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

GlobalDataが出版した調査資料(DATA8014228)・商品コード:DATA8014228
・発行会社(調査会社):GlobalData
・発行日:2017年11月22日
・ページ数:33
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥28,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥56,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥84,750見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000を加算
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Summary
G1 Therapeutics Inc (G1 Therapeutics), formerly G Zero Therapeutics Inc is a healthcare company that develops novel, and small molecule therapies. The company pipeline products include CDK4/6, trilaciclib G1T28 a drug candidate; G1T38 a potential best compound, and G1T48. It undertakes discovery and development of innovative small molecules for utilization in cancer therapy and biodefense applications. G1 Therapeutics discovers new small molecule-based methods that prevent the hematological side effects of cancer chemotherapy and exposure to ionizing radiation. The company also develops small molecules to target specific proteins associated with cell proliferation and growth. It operates through its laboratory located Research Triangle Park. G1 Therapeutics is headquartered in Research Triangle Park, North Carolina, the US.

G1 Therapeutics Inc (GTHX) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
G1 Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
G1 Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
G1 Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
G1 Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
G1 Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
G1 Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
G1 Therapeutics Raises USD47 Million in Series C Financing 11
G1 Therapeutics Raises USD33 Million in Series B Financing 13
G1 Therapeutics Raises US$12.5 Million In Series A Financing 15
G-Zero Therapeutics Raises US$1.3 Million In Venture Financing 16
G1 Therapeutics Raises US$0.6 Million In Seed Financing 17
G1 Therapeutics Raises US$0.8 Million In Venture Financing 18
Partnerships 19
G1 Therapeutics Enters into Agreement with Genentech 19
Licensing Agreements 20
G1 Therapeutics Amends Licensing Agreement with Board of Trustees of the University of Illinois 20
Equity Offering 21
G1 Therapeutics Raises USD116.7 Million in IPO 21
G1 Therapeutics Inc – Key Competitors 23
G1 Therapeutics Inc – Key Employees 24
G1 Therapeutics Inc – Locations And Subsidiaries 25
Head Office 25
Recent Developments 26
Financial Announcements 26
Nov 08, 2017: G1 Therapeutics Reports Third Quarter 2017 Financial Results and Recent Operational Highlights 26
Aug 09, 2017: G1 Therapeutics Reports Second Quarter 2017 Financial Results and Recent Operational Highlights 27
Corporate Communications 29
Jul 13, 2017: G1 Therapeutics Appoints Sir Andrew Witty to Board of Directors 29
Product News 30
04/15/2016: G1 Therapeutics to Present Preliminary clinical data on CDK4/6 Inhibitor G1T28 at the 2016 American Association for Cancer Research Annual Meeting 30
Clinical Trials 31
Jan 10, 2017: G1 Therapeutics Initiates Phase 2 trial of Trilaciclib in Triple-Negative Breast Cancer 31
Nov 21, 2016: G1 Therapeutics to Present Positive Clinical and Preclinical Data on CDK4/6 Inhibitor G1T28 at December Scientific Conferences 32
Appendix 33
Methodology 33
About GlobalData 33
Contact Us 33
Disclaimer 33

List of Tables
G1 Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
G1 Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
G1 Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
G1 Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
G1 Therapeutics Inc, Deals By Therapy Area, 2011 to YTD 2017 8
G1 Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
G1 Therapeutics Raises USD47 Million in Series C Financing 11
G1 Therapeutics Raises USD33 Million in Series B Financing 13
G1 Therapeutics Raises US$12.5 Million In Series A Financing 15
G-Zero Therapeutics Raises US$1.3 Million In Venture Financing 16
G1 Therapeutics Raises US$0.6 Million In Seed Financing 17
G1 Therapeutics Raises US$0.8 Million In Venture Financing 18
G1 Therapeutics Enters into Agreement with Genentech 19
G1 Therapeutics Amends Licensing Agreement with Board of Trustees of the University of Illinois 20
G1 Therapeutics Raises USD116.7 Million in IPO 21
G1 Therapeutics Inc, Key Competitors 23
G1 Therapeutics Inc, Key Employees 24

★調査レポート[G1 Therapeutics Inc (GTHX)-製薬・医療分野:企業M&A・提携分析] (コード:DATA8014228)販売に関する免責事項を必ずご確認ください。
★調査レポート[G1 Therapeutics Inc (GTHX)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆